153 related articles for article (PubMed ID: 21055937)
21. Prevention of muscle fibrosis and myonecrosis in mdx mice by suramin, a TGF-β1 blocker.
Taniguti AP; Pertille A; Matsumura CY; Santo Neto H; Marques MJ
Muscle Nerve; 2011 Jan; 43(1):82-7. PubMed ID: 21108244
[TBL] [Abstract][Full Text] [Related]
22. Curcumin alleviates dystrophic muscle pathology in mdx mice.
Pan Y; Chen C; Shen Y; Zhu CH; Wang G; Wang XC; Chen HQ; Zhu MS
Mol Cells; 2008 Jun; 25(4):531-7. PubMed ID: 18460899
[TBL] [Abstract][Full Text] [Related]
23. Functional improvement of dystrophic muscle by myostatin blockade.
Bogdanovich S; Krag TO; Barton ER; Morris LD; Whittemore LA; Ahima RS; Khurana TS
Nature; 2002 Nov; 420(6914):418-21. PubMed ID: 12459784
[TBL] [Abstract][Full Text] [Related]
24. Targeting the immune system to improve ventilatory function in muscular dystrophy.
Gosselin LE; McCormick KM
Med Sci Sports Exerc; 2004 Jan; 36(1):44-51. PubMed ID: 14707767
[TBL] [Abstract][Full Text] [Related]
25. Normal myoblast implantation in MDX mice prevents muscle damage by exercise.
Brussee V; Merly F; Tardif F; Tremblay JP
Biochem Biophys Res Commun; 1998 Sep; 250(2):321-7. PubMed ID: 9753628
[TBL] [Abstract][Full Text] [Related]
26. Electromyographic studies in mdx and wild-type C57 mice.
Han JJ; Carter GT; Ra JJ; Abresch RT; Chamberlain JS; Robinson LR
Muscle Nerve; 2006 Feb; 33(2):208-14. PubMed ID: 16281275
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological activation of PPARbeta/delta stimulates utrophin A expression in skeletal muscle fibers and restores sarcolemmal integrity in mature mdx mice.
Miura P; Chakkalakal JV; Boudreault L; Bélanger G; Hébert RL; Renaud JM; Jasmin BJ
Hum Mol Genet; 2009 Dec; 18(23):4640-9. PubMed ID: 19744959
[TBL] [Abstract][Full Text] [Related]
28. Intestine of dystrophic mice presents enhanced contractile resistance to stretching despite morphological impairment.
Alves GA; Silva LR; Rosa EF; Aboulafia J; Freymüller-Haapalainen E; Souccar C; Nouailhetas VL
Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(3):G191-9. PubMed ID: 24284964
[TBL] [Abstract][Full Text] [Related]
29. Muscle-bone interactions in dystrophin-deficient and myostatin-deficient mice.
Montgomery E; Pennington C; Isales CM; Hamrick MW
Anat Rec A Discov Mol Cell Evol Biol; 2005 Sep; 286(1):814-22. PubMed ID: 16078270
[TBL] [Abstract][Full Text] [Related]
30. Dystrophin expression following the transplantation of normal muscle precursor cells protects mdx muscle from contraction-induced damage.
Rousseau J; Dumont N; Lebel C; Quenneville SP; Côté CH; Frenette J; Tremblay JP
Cell Transplant; 2010; 19(5):589-96. PubMed ID: 20650035
[TBL] [Abstract][Full Text] [Related]
31. Influence of hindlimb suspension on calcium-induced contraction characteristics in dystrophin-deficient animals.
Litvinova KS; Shenkman BS
J Gravit Physiol; 2007 Jul; 14(1):P91-2. PubMed ID: 18372714
[TBL] [Abstract][Full Text] [Related]
32. Stra13 regulates oxidative stress mediated skeletal muscle degeneration.
Vercherat C; Chung TK; Yalcin S; Gulbagci N; Gopinadhan S; Ghaffari S; Taneja R
Hum Mol Genet; 2009 Nov; 18(22):4304-16. PubMed ID: 19679564
[TBL] [Abstract][Full Text] [Related]
33. IGF-II ameliorates the dystrophic phenotype and coordinately down-regulates programmed cell death.
Smith J; Goldsmith C; Ward A; LeDieu R
Cell Death Differ; 2000 Nov; 7(11):1109-18. PubMed ID: 11139285
[TBL] [Abstract][Full Text] [Related]
34. Nicotinic acetylcholine receptor activation reduces skeletal muscle inflammation of mdx mice.
Leite PE; Lagrota-Candido J; Moraes L; D'Elia L; Pinheiro DF; da Silva RF; Yamasaki EN; Quirico-Santos T
J Neuroimmunol; 2010 Oct; 227(1-2):44-51. PubMed ID: 20615555
[TBL] [Abstract][Full Text] [Related]
35. Soluble TNF-α receptor secretion from healthy or dystrophic mice after AAV6-mediated muscle gene transfer.
Moulay G; Masurier C; Bigey P; Scherman D; Kichler A
Gene Ther; 2010 Nov; 17(11):1400-10. PubMed ID: 20596058
[TBL] [Abstract][Full Text] [Related]
36. Intrinsic laryngeal muscles are spared from myonecrosis in the mdx mouse model of Duchenne muscular dystrophy.
Marques MJ; Ferretti R; Vomero VU; Minatel E; Neto HS
Muscle Nerve; 2007 Mar; 35(3):349-53. PubMed ID: 17143878
[TBL] [Abstract][Full Text] [Related]
37. Progressive nuclear factor-kappaB activation resistant to inhibition by contraction and curcumin in mdx mice.
Durham WJ; Arbogast S; Gerken E; Li YP; Reid MB
Muscle Nerve; 2006 Sep; 34(3):298-303. PubMed ID: 16718687
[TBL] [Abstract][Full Text] [Related]
38. Eicosapentaenoic acid decreases TNF-α and protects dystrophic muscles of mdx mice from degeneration.
Machado RV; Mauricio AF; Taniguti AP; Ferretti R; Neto HS; Marques MJ
J Neuroimmunol; 2011 Mar; 232(1-2):145-50. PubMed ID: 21131061
[TBL] [Abstract][Full Text] [Related]
39. N-acetylcysteine treatment reduces TNF-α levels and myonecrosis in diaphragm muscle of mdx mice.
de Senzi Moraes Pinto R; Ferretti R; Moraes LH; Neto HS; Marques MJ; Minatel E
Clin Nutr; 2013 Jun; 32(3):472-5. PubMed ID: 22727548
[TBL] [Abstract][Full Text] [Related]
40. Long-term administration of the TNF blocking drug Remicade (cV1q) to mdx mice reduces skeletal and cardiac muscle fibrosis, but negatively impacts cardiac function.
Ermolova NV; Martinez L; Vetrone SA; Jordan MC; Roos KP; Sweeney HL; Spencer MJ
Neuromuscul Disord; 2014 Jul; 24(7):583-95. PubMed ID: 24844454
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
